USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 23.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 05.10.2026 | 05.10.2026 | Liquidia Corp. | Stephen M. Bloch | Director | Verkauf | 6.387.596,20 USD |
| 05.10.2026 | 05.10.2026 | PBF Energy Inc. | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | Verkauf | 10.095.096,00 USD |
| 05.10.2026 | 05.10.2026 | United Maritime Corp. | Stavros Gyftakis | See Remarks / Director | Verkauf | 13.451,00 USD |
| 05.10.2026 | 05.10.2026 | Seanergy Maritime Holdings Corp. | Stavros Gyftakis | See Remarks | Verkauf | 49.666,08 USD |
| 05.10.2026 | 05.10.2026 | Amylyx Pharmaceuticals, Inc. | George M. Milne Jr. | Director | Verkauf | 830.904,00 USD |
| 05.10.2026 | 05.10.2026 | Global-E Online Ltd. | Shahar Tamari | COO / Director | Verkauf | 8.203,19 USD |
| 05.10.2026 | 05.10.2026 | Global-E Online Ltd. | Shahar Tamari | COO / Director | Verkauf | 988.475,18 USD |
| 05.10.2026 | 05.10.2026 | Corebridge Financial, Inc. | Nippon Life Insurance Co. | 10% Owner | Kauf | 2.283.647,81 USD |
| 05.10.2026 | 05.10.2026 | 4D Molecular Therapeutics, Inc. | David Kirn | See Remarks / Director | Verkauf | 3.702,03 USD |
| 05.10.2026 | 05.10.2026 | 4D Molecular Therapeutics, Inc. | David Kirn | See Remarks / Director | Verkauf | 750.235,21 USD |
| 05.10.2026 | 05.10.2026 | Glaukos Corp. | Tomas Navratil | CHIEF DEVELOPMENT OFFICER | Verkauf | 51.667,20 USD |
| 05.10.2026 | 05.10.2026 | Glaukos Corp. | Tomas Navratil | CHIEF DEVELOPMENT OFFICER | Verkauf | 53.883,06 USD |
| 05.10.2026 | 05.10.2026 | Glaukos Corp. | Tomas Navratil | CHIEF DEVELOPMENT OFFICER | Verkauf | 145.569,84 USD |
| 05.10.2026 | 05.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 2.989.111,00 USD |
| 05.10.2026 | 05.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 5.101.920,00 USD |
| 05.10.2026 | 05.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 132.272,00 USD |
| 05.10.2026 | 05.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 99.204,00 USD |
| 05.10.2026 | 05.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 3.324.515,00 USD |
| 05.10.2026 | 05.10.2026 | Axia Energia S.A. | de Lima Filho Pedro Batista | Director | Verkauf | 14.775.491,00 USD |
| 05.10.2026 | 05.10.2026 | Stagewise Strategies Corp. | Jakhongir Abidovich Artikkhodjaev | 10% Owner | Verkauf | 138.000,00 USD |
| 05.10.2026 | 05.10.2026 | Stagewise Strategies Corp. | Tourism & Entertainment Group, LLC | 10% Owner | Kauf | 138.000,00 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 9.335,50 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 30.199,36 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 61.115,83 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 59.391,88 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 87.958,31 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 205.763,10 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 96.803,94 USD |
| 05.10.2026 | 05.10.2026 | Twist Bioscience Corp. | Emily M. Leproust | Chief Executive Officer / Director | Verkauf | 368.805,74 USD |
| 05.10.2026 | 06.10.2026 | GAP Inc. | William Sydney Fisher | Director / 10% Owner | Verkauf | 11.945.000,00 USD |
| 05.10.2026 | 05.10.2026 | GAP Inc. | William Sydney Fisher | Director / 10% Owner | Verkauf | 10.125.867,60 USD |
| 05.10.2026 | 06.10.2026 | Generac Holdings Inc. | Norman P. Taffe | President Generac Home | Verkauf | 33.000,00 USD |
| 05.10.2026 | 05.10.2026 | Generac Holdings Inc. | Norman P. Taffe | President Generac Home | Verkauf | 21.546,00 USD |
| 05.10.2026 | 05.10.2026 | Generac Holdings Inc. | Norman P. Taffe | President Generac Home | Verkauf | 21.546,00 USD |
| 05.10.2026 | 05.10.2026 | Generac Holdings Inc. | Norman P. Taffe | President Generac Home | Verkauf | 43.092,00 USD |
| 05.10.2026 | 06.10.2026 | Workday, Inc. | Zane Rowe | Chief Financial Officer | Verkauf | 151.396,88 USD |
| 05.10.2026 | 06.10.2026 | Workday, Inc. | Zane Rowe | Chief Financial Officer | Verkauf | 207.253,97 USD |
| 05.10.2026 | 06.10.2026 | Workday, Inc. | Zane Rowe | Chief Financial Officer | Verkauf | 187.171,40 USD |
| 05.10.2026 | 06.10.2026 | Workday, Inc. | Zane Rowe | Chief Financial Officer | Verkauf | 522.066,16 USD |
| 05.10.2026 | 06.10.2026 | Workday, Inc. | Zane Rowe | Chief Financial Officer | Verkauf | 55.497,00 USD |
| 05.10.2026 | 05.10.2026 | Twilio Inc. | Khozema Shipchandler | Chief Executive Officer / Director | Verkauf | 751.346,03 USD |
| 05.10.2026 | 05.10.2026 | Twilio Inc. | Khozema Shipchandler | Chief Executive Officer / Director | Verkauf | 469.020,48 USD |
| 05.10.2026 | 05.10.2026 | Twilio Inc. | Khozema Shipchandler | Chief Executive Officer / Director | Verkauf | 233.863,04 USD |
| 05.10.2026 | 05.10.2026 | Twilio Inc. | Khozema Shipchandler | Chief Executive Officer / Director | Verkauf | 146.025,27 USD |
| 05.10.2026 | 05.10.2026 | Twilio Inc. | Khozema Shipchandler | Chief Executive Officer / Director | Verkauf | 1.496.476,41 USD |
| 05.10.2026 | 05.10.2026 | Twilio Inc. | Khozema Shipchandler | Chief Executive Officer / Director | Verkauf | 549.353,08 USD |
| 05.10.2026 | 05.10.2026 | Twilio Inc. | Khozema Shipchandler | Chief Executive Officer / Director | Verkauf | 557.036,10 USD |
| 05.10.2026 | 05.10.2026 | Mexico Fund Inc. 🔥 Cluster | Saba Capital Management, L.P. | 10% Owner | Kauf | 520.331,00 USD |
| 05.10.2026 | 05.10.2026 | NEW Germany Fund Inc. | Saba Capital Management, L.P. | 10% Owner | Kauf | 264.263,44 USD |
| 05.10.2026 | 05.10.2026 | Gabelli Healthcare & Wellnessrx Trust | Saba Capital Management, L.P. | 10% Owner | Kauf | 16.649,50 USD |